Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
75 hedge funds and large institutions have $220M invested in Kindred Biosciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
25% more capital invested
Capital invested by funds: $177M → $220M (+$43.8M)
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
4% more funds holding
Funds holding: 72 → 75 (+3)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$463K |
| 2 |
State Street
Boston,
Massachusetts
|
+$429K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$242K |
| 4 |
Squarepoint
New York
|
+$210K |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$975K |
| 2 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
-$971K |
| 3 |
Goldman Sachs
New York
|
-$905K |
| 4 |
Morgan Stanley
New York
|
-$605K |
| 5 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
-$440K |
KIN Hedge Fund Activity: Q4 2019 in Review
75 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2019, worth a combined $220M — up 25% from $177M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KIN positions and 7 closed out — a net gain of 4 holders — while 21 added to existing stakes and 17 trimmed.
The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $463K. The largest seller was Ariel Investments, cutting an estimated $975K.
- 75 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2019, up from 72 in Q3 2019.
- Funds reported $220M of Kindred Biosciences, Inc. stock for Q4 2019, up 25% quarter-over-quarter.
- 11 funds opened new Kindred Biosciences, Inc. positions in Q4 2019 and 7 closed out, a net change of +4 holders.
- The largest Kindred Biosciences, Inc. buyer in Q4 2019 was California Public Employees Retirement System, an estimated $463K added.
- The largest Kindred Biosciences, Inc. seller in Q4 2019 was Ariel Investments, an estimated $975K sold.
Based on aggregated 13F filings for Q4 2019.